Ritalin®
Manufacturer:
CibaGeneva Pharmaceuticals
Uses: Used to treat attention-deficit problems.
More Information
In a new study scientists have linked Ritalin, the most popular drug used to
treat attention-deficit problems with increased risks of cancer. The study of 12
children on Ritalin found every one experienced a significant increase in their
level of chromosome abnormalities occurrences associated with increased risks of
cancer and other adverse health effects.
Marvin Legator, a professor of environmental toxicology at the University of
Texas Medical Branch at Galveston and the study's principal investigator and
senior author, said, "Assuming it holds up, this study doesn't mean these kids
are going to get cancer, but it does mean they're exposed to an additional risk
factor. Smoking doesn't mean you'll get cancer. It's a risk factor."
The study is the first to look at the potential chromosome-damaging effects
associated with methylphenidate, the generic name for Ritalin, the most widely
prescribed drug used to treat attention deficit/hyperactivity disorder (ADHD).
Between 1991 and 1999, U.S. sales of Ritalin and its variants, including
Concerta and Metadata CD, increased more than 500 percent.
Side Effects
- inattention
- hyperactivity
- impulsivity
- robotic
- lethargic
- depression
- withdrawl on stimulants
For more information:
Pharmaceutical Litigation
Prescription
Injury FAQs
Pharmaceutical Legal Glossary
Resources
|
